FDA.reportPublic FDA data

Application 202235

Type
ANDA
Sponsor
SAGENT PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001IBANDRONATE SODIUMIBANDRONATE SODIUMINJECTABLE;INTRAVENOUSEQ 3MG BASE/3MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
25021-827ibandronate sodiumibandronate sodiumSagent PharmaceuticalsANDACurrent
25021-827ibandronate sodiumibandronate sodiumSagent PharmaceuticalsANDACurrent
25021-827ibandronate sodiumibandronate sodiumSagent PharmaceuticalsANDACurrent